Runx1 deficient HSCs replicate slowly and persist in the bone marrow, providing a pool of preleukemic HSCs poised to acquire secondary mutations that would promote their growth and progression to MDS or AML. The gene discussed is RUNX1; the disease is myelodysplastic syndrome.